Key Points Bought 6,565,709 shares of ImmunityBio, an increase of $16.15 million in position value This new position ranks as the fund's 2nd-largest holding, representing 4.4% of AUM These 10 stocks could mint the next wave of millionaires › Heights Capital Management recently established a new position in ImmunityBio (NASDAQ:IBRX), buying 6,565,709 shares valued at approximately $16.15 million. What happened Heights Capital Management disclosed a new purchase of 6,565,709 ImmunityBio shares in i ...